Trials / Completed
CompletedNCT03417050
Synergy Between PCI With TAXUS and Cardiac Surgery: SYNTAX Extended Survival
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,636 (actual)
- Sponsor
- Erasmus Medical Center · Academic / Other
- Sex
- All
- Age
- 21 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
An investigator-driven, retrospective study to compare long-term survival-data (10-year follow-up) of patients with coronary artery disease (CAD), previously enrolled in the SYNTAX trial, who were randomized to percutaneous coronary intervention (PCI) using a paclitaxel (TAXUS) drug-eluting-stent (DES) or coronary artery bypass grafting (CABG).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention will take place for this retrospective and observational study. | No intervention will take place for this retrospective and observational study. |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2019-08-08
- Completion
- 2019-08-08
- First posted
- 2018-01-31
- Last updated
- 2020-01-29
Source: ClinicalTrials.gov record NCT03417050. Inclusion in this directory is not an endorsement.